Back to top
more

West Pharmaceutical Services (WST)

(Real Time Quote from BATS)

$318.00 USD

318.00
40,011

-0.02 (-0.01%)

Updated Jul 23, 2024 10:10 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (160 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Align Technology (ALGN) Launches New Features in iTero Family

by Zacks Equity Research

Align Technology's (ALGN) iTero Workflow 2.0 software and iTero Element 5D Imaging system auto-upload functionality to drive innovation in digital orthodontics and restorative dentistry.

Zimmer Biomet (ZBH) Witnesses Post-Pandemic Business Revival

by Zacks Equity Research

Zimmer Biomet's (ZBH) spin-off decision of the non-core dental and spine business is expected to prove strategic.

Henry Schein (HSIC) Clinches HHS Deal for COVID-19 Supplies

by Zacks Equity Research

Henry Schein (HSIC) to extend effective inventory management and extensive logistical support for PPE and COVID related products within the spectrum of U.S. health care.

Medtronic (MDT) Diabetes Arm Secures Two Approvals in Europe

by Zacks Equity Research

These two latest innovations are likely to enable Medtronic (MDT) to offer the only pump that adjusts and corrects every five minutes with an infusion set that lasts twice as long.

3 Reasons Growth Investors Will Love West Pharmaceutical (WST)

by Zacks Equity Research

West Pharmaceutical (WST) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Why Growth Investors Shouldn't Overlook West Pharmaceutical (WST)

by Zacks Equity Research

West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.

Amedisys (AMED) to Buy VNA Hospice, Home Health, Expand in NE

by Zacks Equity Research

The acquisition is going to expand Amedisys' (AMED) presence in Omaha and Council Bluffs' healthcare communities.

    Zimmer Biomet's (ZBH) Recovery to Continue Despite Pandemic

    by Zacks Equity Research

    Zimmer Biomet's (ZBH) spin-off decision of the non-core dental and spine business is expected to prove strategic.

    Zacks.com featured highlights include: DAQO New Energy, Louisiana Pacific, Nucor Corp, West Pharmaceutical Services and PulteGroup

    by Zacks Equity Research

    Zacks.com featured highlights include: DAQO New Energy, Louisiana Pacific, Nucor Corp, West Pharmaceutical Services and PulteGroup

    Aparajita Dutta headshot

    5 Stocks With Low Debt-to-Equity Ratio to Boost Your Portfolio

    by Aparajita Dutta

    For a prudent investor, a safe strategy of choosing stocks should include search for stocks that bear a low leverage. You may buy DQ, LPX, NUE, WST and PHM.

    LabCorp (LH) Base Line Growth Solid, COVID-Related Sales Drop

    by Zacks Equity Research

    LabCorp's (LH) Walgreens-partnership expands to include new integrated digital experiences.

    Henry Schein (HSIC) Hits 52-Week High, Can the Run Continue?

    by Zacks Equity Research

    Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Sejuti Banerjea headshot

    These 5 Growth Stocks Are Worth a Closer Look

    by Sejuti Banerjea

    This may be a good time to invest in growth stocks.

    West Pharmaceutical (WST) Hits 52-Week High, Can the Run Continue?

    by Zacks Equity Research

    West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Illumina (ILMN) Q1 Earnings Top Estimates, Margins Decline

    by Zacks Equity Research

    Illumina (ILMN) exhibits an impressive performance by its Instruments segment in the first quarter of 2021 despite pandemic-led business disruptions.

    West Pharmaceutical Services (WST) Reports Next Week: Wall Street Expects Earnings Growth

    by Zacks Equity Research

    West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

    by Zacks Equity Research

    Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

    Trina Mukherjee headshot

    3 Stocks to Capitalize on Promising Dental Supplies Industry

    by Trina Mukherjee

    Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

    Sreoshi Bera headshot

    Steady Rise in ESG Investing to Boost These 5 Stocks

    by Sreoshi Bera

    ESG investing will continue its northward momentum and this calls for investing in NVIDIA (NVDA), Microsoft (MSFT), EMCOR (EME), West Pharma (WST) and Texas Instruments (TXN)

    West Pharmaceutical Services (WST) Q4 Earnings and Revenues Beat Estimates

    by Zacks Equity Research

    West Pharmaceutical (WST) delivered earnings and revenue surprises of 18.58% and 7.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

    Debanjana Dey headshot

    5 MedTech Stocks That Have Outperformed the Industry in 2020

    by Debanjana Dey

    Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.

    Trina Mukherjee headshot

    Grab 3 Dental Stocks More Than Doubling Industry Gains for 2021

    by Trina Mukherjee

    Buy these three top dental stocks that have shown sharp recovery despite market volatility due to the pandemic, and have the potential to continue their bull run in 2021.

    MCK vs. WST: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    MCK vs. WST: Which Stock Is the Better Value Option?

    Has West Pharmaceutical Services (WST) Outpaced Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (WST) Outperforming Other Medical Stocks This Year?

    Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (WST) Outperforming Other Medical Stocks This Year?